Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Perspective Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CATX: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4250+8
Shares27.9M33.0M+5.10M (+18.3%)
Value$17.8M$22.0M+$4.24M (+23.8%)

New holders (13)

Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CATX in Q2 2023
InstitutionSharesValue% of portfolio
Baker Bros. Advisors LP2,319,286$1.55M0.01%
Portland Investment Counsel Inc.1,034,100$683.0K0.34%
Citadel Advisors LLC166,779$111.4K0.00%
Two Sigma Securities, LLC100,771$67.3K0.01%
BerganKDV Wealth Management, LLC75,000$50.1K0.01%
Thrivent Financial for Lutherans40,000$27.0K0.00%
Susquehanna International Group, LLP16,470$11.0K0.00%
Congress Wealth Management LLC15,000$10.0K0.00%
Mendota Financial Group, LLC15,000$10.0K0.01%
KilterHowling LLC14,625$9.77K0.01%
Jane Street Group, LLC12,219$8.16K0.00%
Advisor Group Holdings, Inc.100$630.00%
FMR LLC27$180.00%

Sold out (5)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CATX in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Crestwood Advisors Group LLC54,824$35.0K
ExodusPoint Capital Management, LP48,719$31.0K
Dynamic Advisor Solutions LLC40,000$25.5K
Sowell Financial Services LLC30,000$19.0K
Advisory Services Network, LLC1,000$638